Silvia Bianchi Selected Research

CADASIL

1/2018	Notch3 protein expression in skin fibroblasts from CADASIL patients.
7/2017	Vitamin D levels in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).
4/2017	Circulating Biomarkers in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Patients.
1/2014	Homozygosity and severity of phenotypic presentation in a CADASIL family.
11/2013	Visual system involvement in CADASIL.
9/2013	First deep intronic mutation in the NOTCH3 gene in a family with late-onset CADASIL.
11/2012	Hereditary cerebral small vessel diseases: a review.
6/2012	Acetazolamide for the prophylaxis of migraine in CADASIL: a preliminary experience.
2/2012	High lipoprotein(a) serum levels in three CADASIL families.
9/2011	First report of a pathogenic mutation on exon 24 of the NOTCH3 gene in a CADASIL family.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Silvia Bianchi Research Topics

Disease

16	CADASIL 01/2018 - 04/2004
6	Infections 01/2019 - 01/2003
4	Stroke (Strokes) 04/2017 - 04/2008
3	Measles 01/2022 - 06/2020
3	Papillomavirus Infections 01/2019 - 01/2013
3	Dementia (Dementias) 01/2018 - 02/2010
2	Cerebral Small Vessel Diseases 07/2017 - 11/2012
2	Migraine Disorders (Migraine) 06/2012 - 06/2004
2	Respiratory Insufficiency (Respiratory Failure) 01/2012 - 10/2011
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2012 - 01/2006
2	Pulmonary Hypertension 08/2006 - 01/2006
1	Hyperparathyroidism 10/2022
1	Breast Neoplasms (Breast Cancer) 06/2022
1	Renal Insufficiency (Renal Failure) 06/2022
1	Myocardial Infarction 06/2022
1	Prostatic Neoplasms (Prostate Cancer) 06/2022
1	Persistent Infection 04/2021
1	Patent Ductus Arteriosus 03/2021
1	Primary Ovarian Insufficiency 01/2021
1	COVID-19 01/2021
1	Squamous Intraepithelial Lesions 01/2020
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2019
1	Disease Progression 01/2019
1	Urge Urinary Incontinence (Urge Incontinence) 01/2018
1	Hemorrhagic Stroke 01/2018
1	Endocarditis 09/2017
1	Leukoencephalopathies 04/2017
1	Lacunar Stroke 04/2017
1	Colorectal Neoplasms (Colorectal Cancer) 01/2015
1	Coinfection 01/2015
1	Hemorrhage 07/2013
1	Fabry Disease (Fabry's Disease) 11/2012
1	Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy 11/2012
1	Asphyxia (Suffocation) 10/2011
1	Hypothermia 10/2011
1	Hepatitis E 01/2011
1	Hydrothorax 10/2010
1	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 02/2010
1	Newcastle Disease 12/2007
1	Aortic Coarctation 08/2006
1	Hernia (Hernias) 08/2006
1	Pneumonia (Pneumonitis) 04/2006
1	Meconium Aspiration Syndrome 01/2006
1	Birth Weight (Birth Weights) 04/2005
1	Transient Ischemic Attack 06/2004
1	Fatigue 06/2004
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 04/2004
1	Herpes Zoster 12/2003

Drug/Important Bio-Agent (IBA)

6	VaccinesIBA 01/2022 - 01/2003
3	DNA (Deoxyribonucleic Acid)IBA 01/2015 - 01/2013
3	Cysteine (L-Cysteine)FDA Link 01/2014 - 04/2008
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2011
2	Notch3 ReceptorIBA 01/2018 - 04/2008
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2018 - 07/2013
2	cytidylyl-(3'-5')-cytidine (CpC)IBA 04/2017 - 02/2010
2	Retinaldehyde (Retinal)IBA 11/2013 - 11/2012
2	Surface-Active Agents (Surfactants)IBA 01/2012 - 01/2006
2	Epidermal Growth Factor (EGF)IBA 09/2011 - 04/2008
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 08/2006 - 01/2006
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 10/2022
1	Attenuated VaccinesIBA 01/2022
1	Acetaminophen (Paracetamol)FDA LinkGeneric 03/2021
1	vasectrin I (VS I)IBA 03/2021
1	Ibuprofen (Motrin)FDA LinkGeneric 03/2021
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2021
1	Immunoglobulin G (IgG)IBA 01/2021
1	Hemagglutinins (Hemagglutinin)IBA 06/2020
1	EpitopesIBA 06/2020
1	Proteins (Proteins, Gene)FDA Link 06/2020
1	Transcription Factors (Transcription Factor)IBA 01/2020
1	Papillomavirus Vaccines (HPV Vaccines)IBA 01/2019
1	hydroxide ionIBA 07/2017
1	Vitamin D FDA LinkGeneric 07/2017
1	Biomarkers (Surrogate Marker)IBA 04/2017
1	von Willebrand FactorIBA 04/2017
1	erucylphosphocholineIBA 04/2017
1	ThrombomodulinIBA 04/2017
1	ParaffinIBA 01/2015
1	AnticoagulantsIBA 07/2013
1	Combined VaccinesIBA 01/2013
1	Acetazolamide (Diamox)FDA LinkGeneric 06/2012
1	Lipoprotein(a)IBA 02/2012
1	Neuroprotective AgentsIBA 10/2011
1	NucleotidesIBA 01/2011
1	Immunoglobulin M (IgM)IBA 01/2011
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 02/2010
1	Pharmaceutical PreparationsIBA 12/2007
1	Lactic Acid (Lactate)FDA LinkGeneric 06/2004
1	Mitochondrial DNA (mtDNA)IBA 06/2004
1	Fluorescein (Funduscein)FDA LinkGeneric 04/2004

Therapy/Procedure

2	Artificial Respiration (Mechanical Ventilation) 01/2012 - 10/2011
2	Therapeutics 10/2011 - 01/2006
1	Surgical Amputation (Amputations) 06/2022
1	Low-Level Light Therapy (LLLT) 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Prostheses and Implants (Prosthesis) 09/2017
1	Rewarming 10/2011
1	Critical Care (Surgical Intensive Care) 10/2010
1	Intermittent Positive-Pressure Ventilation 04/2006
1	Cesarean Section (Caesarean Section) 04/2005